These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31697182)

  • 1. Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
    Tweden KS; Deiss D; Rastogi R; Addaguduru S; Kaufman FR
    Diabetes Technol Ther; 2020 May; 22(5):422-427. PubMed ID: 31697182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor.
    Sanchez P; Ghosh-Dastidar S; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2019 Dec; 21(12):677-681. PubMed ID: 31385732
    [No Abstract]   [Full Text] [Related]  

  • 3. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.
    Wadwa RP; Laffel LM; Shah VN; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):395-402. PubMed ID: 29901421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.
    Christiansen MP; Klaff LJ; Brazg R; Chang AR; Levy CJ; Lam D; Denham DS; Atiee G; Bode BW; Walters SJ; Kelley L; Bailey TS
    Diabetes Technol Ther; 2018 Mar; 20(3):197-206. PubMed ID: 29381090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System.
    Deiss D; Szadkowska A; Gordon D; Mallipedhi A; Schütz-Fuhrmann I; Aguilera E; Ringsell C; De Block C; Irace C
    Diabetes Technol Ther; 2019 May; 21(5):254-264. PubMed ID: 31021180
    [No Abstract]   [Full Text] [Related]  

  • 6. A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study.
    Christiansen MP; Klaff LJ; Bailey TS; Brazg R; Carlson G; Tweden KS
    Diabetes Technol Ther; 2019 May; 21(5):231-237. PubMed ID: 30925083
    [No Abstract]   [Full Text] [Related]  

  • 7. Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.
    Kropff J; Choudhary P; Neupane S; Barnard K; Bain SC; Kapitza C; Forst T; Link M; Dehennis A; DeVries JH
    Diabetes Care; 2017 Jan; 40(1):63-68. PubMed ID: 27815290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Home Study on Nocturnal Hypoglycemic Alarms Using a New Fully Implantable Continuous Glucose Monitoring System in Type 1 Diabetes.
    Wang X; Ioacara S; DeHennis A
    Diabetes Technol Ther; 2015 Nov; 17(11):780-6. PubMed ID: 26177299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance of Subcutaneous Continuous Glucose Monitoring in Adult Critically Ill Patients Receiving Vasopressor Therapy.
    Friman O; Soltani N; Lind M; Zetterqvist P; Balintescu A; Perner A; Oldner A; Rooyackers O; Mårtensson J
    Diabetes Technol Ther; 2024 Oct; 26(10):763-772. PubMed ID: 38758211
    [No Abstract]   [Full Text] [Related]  

  • 11. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
    Garg SK; Liljenquist D; Bode B; Christiansen MP; Bailey TS; Brazg RL; Denham DS; Chang AR; Akturk HK; Dehennis A; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2022 Feb; 24(2):84-92. PubMed ID: 34515521
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy.
    Irace C; Cutruzzolà A; Tweden K; Kaufman FR
    Expert Rev Med Devices; 2021 Oct; 18(10):909-914. PubMed ID: 34528851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.
    Irace C; Cutruzzolà A; Nuzzi A; Assaloni R; Brunato B; Pitocco D; Tartaglione L; Di Molfetta S; Cignarelli A; Laviola L; Citro G; Lovati E; Gnasso A; Tweden KS; Kaufman FR
    Diabetes Obes Metab; 2020 Jul; 22(7):1056-1061. PubMed ID: 32037699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.
    Thabit H; Leelarathna L; Wilinska ME; Elleri D; Allen JM; Lubina-Solomon A; Walkinshaw E; Stadler M; Choudhary P; Mader JK; Dellweg S; Benesch C; Pieber TR; Arnolds S; Heller SR; Amiel SA; Dunger D; Evans ML; Hovorka R
    Diabetes Technol Ther; 2015 Nov; 17(11):801-7. PubMed ID: 26241693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus.
    Faccioli S; Del Favero S; Visentin R; Bonfanti R; Iafusco D; Rabbone I; Marigliano M; Schiaffini R; Bruttomesso D; Cobelli C;
    J Diabetes Sci Technol; 2017 Nov; 11(6):1147-1154. PubMed ID: 28486841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
    Peyser TA; Nakamura K; Price D; Bohnett LC; Hirsch IB; Balo A
    Diabetes Technol Ther; 2015 Aug; 17(8):548-54. PubMed ID: 25961446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1-year real-world assessment.
    Rizzi A; Tartaglione L; Lucaccini Paoli L; Leo ML; Popolla V; Viti L; Barberio A; Di Leo M; Pontecorvi A; Pitocco D
    Diabetes Obes Metab; 2024 Sep; 26(9):4078-4086. PubMed ID: 39010292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.